AGL (amylo-1, 6-glucosidase, 4-alpha-glucanotransferase), also known as GDE (Glycogen debranching enzyme), is a 1,532 amino acid protein that exists as three alternatively spliced isoforms which are expressed in kidney, liver, heart and muscle in an isoform-specific manner. Exhibiting multifunctional enzyme capabilities, AGL contains two catalytic active sites, one of which acts as an 4-alpha-glucotransferase and the other of which acts as an amylo-1,6-glucosidase during glycogen degradation. Defects in the gene encoding AGL are the cause of glycogen storage disease type 3 (GSD3), also known as Forbes disease. GSD3 is a metabolic disorder that is characterized by the presence of abnormal glycogen due to a lack of AGL activity. Symptoms of GSD3 generally include hypoglycemia, variable myopathy, hepatomegaly and short stature.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPELISA
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of AGL of human origin by WB IP and ELISA
Tissue Specificity
recommended for detection of AGL of human origin by WB, IP and ELISA